Table 1 Correlation of NFKB1 and RELA expression with clinicopathologic parameters (significant P-value in bold and Italic format; #, marginally significant)
NFKB1 expression | RELA expression | ||||||
|---|---|---|---|---|---|---|---|
Negative number (%) | Positive number (%) | P-value | Negative number (%) | Positive number (%) | P-value | ||
Sex | M | 30 (44.1) | 38 (55.9) | 0.199 | 25 (36.8) | 43 (63.2) | 0.135 |
F | 19 (59.4) | 13 (40.6) | 17 (53.1) | 15 (46.9) | |||
Age | <=60 | 20 (64.5) | 11 (35.5) | 0.052# | 15 (48.4) | 16 (51.6) | 0.392 |
>60 | 29 (42.0) | 40 (58.0) | 27 (39.1) | 42 (60.9) | |||
Type | Intestinal | 32 (49.2) | 33 (50.8) | 1.000 | 26 (40.0) | 39 (60.0) | 0.672 |
Diffuse | 17 (63.0) | 10 (37.0) | 16 (45.7) | 19 (54.3) | |||
Grade | 1 | 2 (40.0) | 3 (60.0) | 0.475 | 1(20.0) | 4 (80.0) | 0.252 |
2 | 18 (42.9) | 24 (57.1) | 15 (35.7) | 27 (64.3) | |||
3 | 29 (54.7) | 24 (45.3) | 26 (49.1) | 27 (40.9) | |||
Stage (T) | 1 | 3 (50.0) | 3 (50.0) | 0.884 | 4 (66.7) | 2 (33.3) | 0.456 |
2 | 14 (48.3) | 15 (51.7) | 13 (44.8) | 16 (55.2) | |||
3 | 27 (47.4) | 30 (52.6) | 23 (40.4) | 34 (59.6) | |||
4 | 5 (55.6) | 3 (44.4) | 2 (25.0) | 6 (75.0) | |||
Stage (N) | 0 | 10 (45.5) | 12(54.5) | 0.605 | 12 (54.5) | 10 (45.5) | 0.042 |
1 | 13 (61.9) | 8 (38.1) | 12 (57.1) | 9 (42.9) | |||
2 | 15 (44.1) | 19 (55.9) | 8 (23.5) | 26 (76.5) | |||
3 | 11 (47.8) | 12 (52.2) | 10 (43.5) | 13 (66.5) | |||
Stage (M) | 0 | 40 (48.2) | 43 (51.8) | 0.794 | 34 (41.0) | 49 (59.0) | 0.788 |
1 | 9 (52.9) | 8 (47.1) | 8 (47.1) | 9 (52.9) | |||
Lymph Node | 0 | 10 (45.5) | 12 (54.5) | 0.811 | 12 (54.5) | 10 (45.5) | 0.223 |
1 | 39 (50.0) | 39 (50.0) | 30 (38.5) | 48 (61.5) | |||
H. pylori | Absence | 19 (54.3) | 16 (45.7) | 0.530 | 14 (40.0) | 21 (60.0) | 0.834 |
Presence | 30 (46.2) | 35 (53.8) | 28 (43.1) | 37 (56.9) | |||